about
Glial Tau Pathology in Tauopathies: Functional ConsequencesCurrent Research Therapeutic Strategies for Alzheimer's Disease TreatmentImaging Multimodalities for Dissecting Alzheimer's Disease: Advanced Technologies of Positron Emission Tomography and Fluorescence ImagingLinking traumatic brain injury to chronic traumatic encephalopathy: identification of potential mechanisms leading to neurofibrillary tangle developmentRescue from tau-induced neuronal dysfunction produces insoluble tau oligomersThe dendritic hypothesis for Alzheimer's disease pathophysiology.Tau StructuresNeurofibrillary tangle-bearing neurons are functionally integrated in cortical circuits in vivo.Roles of tau protein in health and disease.Wild-Type, but Not Mutant N296H, Human Tau Restores Aβ-Mediated Inhibition of LTP in Tau-/- mice.Formation and spreading of TDP-43 aggregates in cultured neuronal and glial cells demonstrated by time-lapse imaging.Structure and mechanism of action of tau aggregation inhibitors.Tau monoclonal antibody generation based on humanized yeast models: impact on Tau oligomerization and diagnosticsIsolation and characterization of antibody fragments selective for toxic oligomeric tauStabilization of Microtubule-Unbound Tau via Tau Phosphorylation at Ser262/356 by Par-1/MARK Contributes to Augmentation of AD-Related Phosphorylation and Aβ42-Induced Tau Toxicity.Microtubule stabilising peptides rescue tau phenotypes in-vivo."Tau oligomers," what we know and what we don't know.Tau protein modifications and interactions: their role in function and dysfunction.Brain pathology in myotonic dystrophy: when tauopathy meets spliceopathy and RNAopathy.Potential mechanisms and implications for the formation of tau oligomeric strains.The Role of the Carboxyl-Terminal Sequence of Tau and MAP2 in the Pathogenesis of DementiaThe Role of Microglia in the Etiology and Evolution of Chronic Traumatic Encephalopathy.Dysregulation of Microtubule Stability Impairs Morphofunctional Connectivity in Primary Neuronal Networks.Identification of key amino acids responsible for the distinct aggregation properties of microtubule-associated protein 2 and tau.Discovery and characterization of stable and toxic Tau/phospholipid oligomeric complexes.Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease.Specific serum antibody binding to phosphorylated and non-phosphorylated tau in non-cognitively impaired, mildly cognitively impaired, and Alzheimer's disease subjects: an exploratory study.What is the evidence that tau pathology spreads through prion-like propagation?Neuroinflammatory responses in Alzheimer's disease.Synaptic Dysfunction in Alzheimer's Disease: Aβ, Tau, and Epigenetic Alterations.Suppressor of Cytokine Signaling 3: Emerging Role Linking Central Insulin Resistance and Alzheimer’s Disease.
P2860
Q26765365-4D0D0A68-C14E-4114-9E23-E6C6663E8E5EQ26765530-5BA39692-061C-4F08-8DBE-578BDF298606Q26770766-F6CB9A0E-B05F-4E06-983B-D9C2266DFB19Q27022997-EBA82314-01E9-48DF-87D8-F3C65C089DF2Q27305025-1583BCEE-D2D4-4A62-A7C7-69D368094F09Q27687404-48CC6F44-FDC2-477C-A64A-CDB8C737864BQ28076921-F66EA078-2DEA-43D3-B39F-FE3821A7AA7AQ30564297-7635502A-B7EE-45CA-8E79-AB7D66C1F112Q33559303-FF497445-589D-473A-AFD5-15594695A402Q33593280-CEBE08F7-60C3-4113-AF7A-71BD7520ED54Q33783811-677B95B2-D379-49AD-8B45-F8D0BAF6B133Q34902096-BDBAE0EA-FE31-4432-A12C-6244F81F83FCQ35080258-200A3BE7-0ABB-4452-B887-ECC20A21AB72Q35137455-0EBDAB79-6AA1-417D-9E9D-7D8925B78B1EQ35972860-4738DC36-4378-4F72-8806-C7D0C236EC56Q37464820-FB8F22B5-79DB-4DEF-947C-3558593F8C20Q37467443-A6475960-6C16-4BBF-AD4C-3512796D22D4Q37684106-A8A884CB-7C53-47F3-A635-A52AFBF46B8AQ38177257-082724C2-CCE2-4158-AC5A-0274BA5A42AFQ38960046-FF89FD1D-CD8F-47F9-9B6B-A9608EDDCA48Q39084544-F2A2AC66-D3A7-4983-8596-E0094BCE7BB3Q39149587-1881D69B-D0D8-4A3F-8126-DBE075A92B07Q41071847-BDDD04F9-FB24-47AC-B364-750B30EDA4E9Q41310684-78202883-CFCB-4405-8AED-BD5D26EF6DCCQ44441688-92629D87-0548-4BB5-A1BA-8F00D9365E49Q46008245-90BD4286-B47E-4D7E-8B02-CE5F958D5088Q47099501-BF8B999C-DC78-4A5E-A08C-98B6D650823EQ47163825-62AD2C34-6D31-4D6D-AC11-2D6AD5FFB329Q47259208-61D2D232-9AB5-4F6F-8380-BF35A681939EQ50440796-654B9F70-F410-4DA1-9E35-C4D038A7C83AQ55405257-21A5FF03-16A6-4942-BACF-D4211CB930A3
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Are tau aggregates toxic or protective in tauopathies?
@en
Are tau aggregates toxic or protective in tauopathies?
@nl
type
label
Are tau aggregates toxic or protective in tauopathies?
@en
Are tau aggregates toxic or protective in tauopathies?
@nl
prefLabel
Are tau aggregates toxic or protective in tauopathies?
@en
Are tau aggregates toxic or protective in tauopathies?
@nl
P2860
P356
P1476
Are tau aggregates toxic or protective in tauopathies?
@en
P2093
Amrit Mudher
Catherine M Cowan
P2860
P356
10.3389/FNEUR.2013.00114
P577
2013-08-13T00:00:00Z